Methods of producing testosteronan polymers using testosteronan synthase

US10273517B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10273517-B2
Application numberUS-201715594860-A
CountryUS
Kind codeB2
Filing dateMay 15, 2017
Priority dateJan 31, 2011
Publication dateApr 30, 2019
Grant dateApr 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Testosteronan, a heparosan analog having the structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , is produced by testosteronan synthase, a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize a polysaccharide having the structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n .

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a polymer, at least a portion of which has the repeat structure [4-D-glucuronic acid-α1,4-D-N-acetylglucosamine-α1-] n ([-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n ), the method comprising the steps of: culturing a recombinant host cell that comprises a nucleic acid encoding an enzymatically active testosteronan synthase, wherein the testosteronan synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize a polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , wherein the recombinant host cell is cultured under conditions that allow for the production of the enzymatically active testosteronan synthase and under conditions that allow the testosteronan synthase to produce the polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , wherein the recombinant host cell is cultured in the presence of at least one UDP-sugar or comprises nucleic acids encoding enzymes which catalyze the synthesis of at least one UDP-sugar, and wherein the nucleotide sequence encoding the enzymatically active testosteronan synthase is defined as: (a) the nucleotide sequence of SEQ ID NO: 2; (b) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 1; (c) a nucleotide sequence encoding an amino acid sequence having up to 30 amino acid insertions, deletions, and/or substitutions when compared to SEQ ID NO: 1; and/or (d) a nucleotide sequence encoding an amino acid sequence having up to 25 amino acid insertions, deletions, and/or substitutions when compared to SEQ ID NO:1; and isolating the polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n . 2. The method of claim 1 , wherein the recombinant host cell comprises nucleic acids encoding enzymes which catalyze the synthesis of UDP-GlcUA and UDP-GlcNAc. 3. The method of claim 1 , further comprising the step of supplying UDP-GlcUA and UDP-GlcNAc to the recombinant host cell. 4. The method of claim 1 , wherein the isolated polymer is substantially monodisperse in size and has a polydispersity value in a range of from 1.0 to 1.5. 5. The method of claim 1 , wherein the recombinant host cell is a prokaryotic cell. 6. The method of claim 1 , wherein the recombinant host cell is a eukaryotic cell. 7. The method of claim 1 , wherein the recombinant host cell further comprises: a nucleic acid encoding an enzymatically active UDP-glucose dehydrogenase; and/or a nucleic acid encoding an enzymatically active UDP-glucose pyrophosphorylase. 8. A method of producing a polymer, at least a portion of which has the repeat [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , the method comprising the steps of: culturing a recombinant host cell in a culture medium under conditions that allow for the production of an enzymatically active testosteronan synthase and under conditions that allow the testosteronan synthase to produce the polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , wherein the recombinant host cell comprises a recombinant vector comprising a nucleotide sequence encoding an enzymatically active testosteronan synthase, wherein the testosteronan synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize a polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , wherein the recombinant host cell is cultured in the presence of at least one UDP-sugar or comprises nucleic acids encoding enzymes which catalyze the synthesis of at least one UDP-sugar, and wherein the nucleotide sequence encoding the enzymatically active testosteronan synthase is defined as: (a) the nucleotide sequence of SEQ ID NO: 2; (b) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 1; and/or (c) a nucleotide sequence encoding an amino acid sequence having up to 25 amino acid insertions, deletions, and/or substitutions when compared to SEQ ID NO:1; and isolating the polymer having the repeat structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n . 9. The method of claim 8 , wherein the polymer is isolated from the culture medium. 10. The method of claim 8 , wherein the recombinant vector further comprises a nucleic acid encoding an enzymatically active UDP-glucose dehydrogenase and/or a nucleic acid encoding an enzymatically active UDP-glucose pyrophosphorylase. 11. The method of claim 8 , wherein the recombinant vector further comprises nucleic acids encoding enzymes which catalyze the synthesis of UDP-GlcUA and UDP-GlcNAc. 12. The method of claim 8 , further comprising the step of supplying UDP-GlcUA and UDP-GlcNAc to the recombinant host cell. 13. The method of claim 8 , wherein the nucleotide sequence of (c) encodes an amino acid sequence having up to 15 amino acid insertions, deletions, and/or substitutions when compared to SEQ ID NO:1. 14. The method of claim 8 , wherein the nucleotide sequence of (c) encodes an amino acid sequence having up to 10 amino acid insertions, deletions, and/or substitutions when compared to SEQ ID NO:1. 15. The method of claim 8 , wherein the nucleotide sequence encoding the enzymatically active testosteronan synthase is defined as: (a) the nucleotide sequence of SEQ ID NO:2; and/or (b) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:1.

Assignees

Inventors

Classifications

  • Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Hexosyltransferases (2.4.1) · CPC title

  • C12P19/26Primary

    Preparation of nitrogen-containing carbohydrates · CPC title

  • UDP-glucose 6-dehydrogenase (1.1.1.22) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10273517B2 cover?
Testosteronan, a heparosan analog having the structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n , is produced by testosteronan synthase, a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize a polysaccharide having the structure [-4-D-GlcUA-α1,4-D-GlcNAc-α1-] n .
Who is the assignee on this patent?
Univ Oklahoma
What technology area does this patent fall under?
Primary CPC classification C12P19/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).